Back to GetFilings.com



PART I
     Item 1.Financial Statements
Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3.Quantitative and Qualitative Disclosures about Market Risk
Item 4.Disclosure Controls and Procedures
PART II
Item 1.Legal Proceedings
Item 6. (a) Exhibits
             (b) Reports on Form 8-K
             Signatures
             Index to Exhibits

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

[X]  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
        For the quarterly period ended September 30, 2003.

                                                or

[   ]  Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
        For the transition period from __________________  to  ________________

Commission file number 1-8485
MILACRON INC.

(Exact name of registrant as specified in its charter)
Delaware No. 31-1062125


(State or other jurisdiction of
 incorporation or organization)
(I.R.S. Employer Identification No.)
2090 Florence Avenue, Cincinnati, Ohio 45206


(Address of principal executive offices) (Zip Code)
(513) 487-5000

(Registrant's telephone number,
including area code)

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [   ]

    Indicate by check mark whether the registrant is an accelerated filer (as defined by Rule 12b-2 of the Exchange Act)

Yes [X] No [   ]

Number of shares of Common Stock, $1.00 par value, outstanding as of November 10, 2003: 34,819,999



Milacron Inc. and Subsidiaries
Index
Page

Part I Financial Information
Item 1.    Financial Statements
      Consolidated Condensed Statements of Earnings 3
      Consolidated Condensed Balance Sheets 4
      Consolidated Condensed Statements of Cash Flows 5
      Notes to Consolidated Condensed Financial Statements 6
Item 2.    Management's Discussion and Analysis of Financial Condition
      and Results of Operations
18
Item 3.    Quantitative and Qualitative Disclosures about Market Risk 30
Item 4.    Disclosure Controls and Procedures 30
Part II Other Information
Item 1.    Legal Proceedings 31
Item 6.    (a) Exhibits 31
   (b) Reports on Form 8-K 31
   Signatures 32
   Index to Exhibits 33

2


PART I Financial Information

Item 1. Financial Statements

Consolidated Condensed Statements of Operations
Milacron Inc. and Subsidiaries
(Unaudited)

    Three Months Ended
Sept. 30,
    Nine Months Ended
Sept. 30,
   
   
(In millions, except share and per-share amounts) 2003    2002 2003    2002

Sales $ 170.2 $ 173.3 $ 542.0 $ 501.7
   Cost of products sold 139.0 141.7 447.1 413.4
   Cost of products sold related to restructuring - - 3.8 -




      Total cost of products sold 139.0 141.7 450.9 413.4




         Manufacturing margins 31.2 31.6 91.1 88.3
Other costs and expenses
   Selling and administrative 30.7 30.9 95.3 90.7
   Goodwill impairment charge 52.3 - 52.3 -
   Restructuring costs 6.4 1.9 14.8 9.8
   Other expense - net (.2 ) 1.5 2.0 .6




      Total other costs and expenses 89.2 34.3 164.4 101.1




Operating loss (58.0 ) (2.7 ) (73.3 ) (12.8 )
Interest
   Income .2 .5 1.2 1.5
   Expense (6.1 ) (7.0 ) (18.1 ) (19.7 )




      Interest-net (5.9 ) (6.5 ) (16.9 ) (18.2 )




Loss from continuing operations before income taxes
   and cumulative effect of change in method of accounting
(63.9 ) (9.2 ) (90.2 ) (31.0 )
Provision (benefit) for income taxes 1.8 (4.7 ) 71.4 (11.6 )




Loss from continuing operations before cumulative
   effect of change in method of accounting
(65.7 ) (4.5 ) (161.6 ) (19.4 )
Discontinued operations net of income taxes
   Loss from operations (2.0 ) (10.4 ) (5.7 ) (24.4 )
   Gain on sale of Valenite - 29.4 - 29.4
   Loss on sale of Widia and Werkö - - - (15.3 )




      Total discontinued operations (2.0 ) 19.0 (5.7 ) (10.3 )
Cumulative effect of change in method of accounting - - - (187.7 )




Net earnings (loss) (67.7 ) 14.5 (167.3 ) (217.4 )




Earnings (loss) per common share - basic and diluted
   Continuing operations $ (1.95 ) $ (.14 ) $ (4.81 ) $ (.59 )
   Discontinued operations (.06 ) .57 (.17 ) (.30 )
   Cumulative effect of change in method of accounting - - - (5.61 )




         Net earnings (loss) $ (2.01 ) $ .43 $ (4.98 ) $ (6.50 )




Dividends per common share $ - $ .01 $ .02 $ .03




Weighted average common shares outstanding assuming
   dilution (in thousands)
33,684 33,508 33,620 33,464

See notes to consolidated condensed financial statements.

3


Consolidated Condensed Balance Sheets
Milacron Inc. and Subsidiaries
(Unaudited)

(In millions, except par value)     Sept. 30,
2003
    Dec. 31,
2002

Assets
Current assets
   Cash and cash equivalents $ 62.8 $ 122.3
   Notes and accounts receivable, less allowances of $13.3 in 2003
      and $12.4 in 2002
102.7 89.3
   Inventories
      Raw materials 19.6 30.5
      Work-in-process and finished parts 86.1 85.7
      Finished products 30.7 31.4


          Total inventories 136.4 147.6
   Other current assets 57.5 69.6


      Current assets of continuing operations 369.4 428.8
   Assets of discontinued operations 9.0 16.0


      Total current assets 368.4 444.8
Property, plant and equipment - net 143.0 149.8
Goodwill 95.1 143.3
Other noncurrent assets 110.5 177.8


Total assets $ 717.0 $ 915.7


Liabilities and Shareholders' Equity (Deficit)
Current liabilities
   Borrowings under lines of credit $ 42.4 $ 45.0
   Long-term debt and capital lease obligations due within one year 116.3 1.1
   Trade accounts payable 66.3 68.8
   Advance billings and deposits 12.1 17.5
   Accrued and other current liabilities 105.9 138.9


      Current liabilities of continuing operations 343.0 271.3
   Liabilities of discontinued operations 2.3 10.9


      Total current liabilities 345.3 282.2
Long-term accrued liabilities 243.6 244.1
Long-term debt 153.8 255.4


   Total liabilities 742.7 781.7
Commitments and contingencies - -
Shareholders' equity (deficit)
   4% Cumulative Preferred shares 6.0 6.0
   Common shares, $1 par value (outstanding: 33.9 in 2003 and 33.8 in 2002) 33.9 33.8
   Capital in excess of par value 284.4 283.5
   Accumulated deficit (227.5 ) (59.5 )
   Accumulated other comprehensive loss (122.5 ) (129.8 )


      Total shareholders' equity (deficit) (25.7 ) 134.0


Total liabilities and shareholders' equity (deficit) $ 717.0 $ 915.7



See notes to consolidated condensed financial statements.

4


Consolidated Condensed Statements of Cash Flows
Milacron Inc. and Subsidiaries
(Unaudited)

    Three Months Ended
Sept. 30,
    Nine Months Ended
Sept. 30,
   
   
(In millions) 2003    2002 2003    2002

Increase (decrease) in cash and cash equivalents
   Operating activities cash flows
       Net earnings (loss) $ (67.7 ) $ 14.5 $ (167.3 ) $ (217.4 )
       Operating activities providing (using) cash
          Loss from discontinued operations 2.0 10.4 5.7 24.4
          Gain on sale of Valenite - (29.4 ) - (29.4 )
          Loss on sale of Widia and Werkö - - - 15.3
          Cumulative effect of change in method of accounting - - - 187.7
          Depreciation and amortization 5.0 6.1 16.3 17.4
          Restructuring costs 6.4 1.9 18.6 9.8
          Goodwill impairment charge 52.3 - 52.3 -
          Deferred income taxes (.3 ) (12.6 ) 68.1 (14.1 )
          Working capital changes
             Notes and accounts receivable (8.2 ) (6.3 ) (6.3 ) (.9 )
             Inventories 8.7 6.3 16.3 28.8
             Other current assets 1.0 2.5 8.9 3.0
             Trade accounts payable 7.4 .4 (5.7 ) (.4 )
             Other current liabilities (10.1 ) 10.9 (29.5 ) 1.9
          Decrease (increase) in other noncurrent assets 2.8 (1.1 ) 1.0 (4.3 )
          Increase (decrease) in long-term accrued liabilities 2.1 (1.0 ) (.4 ) (1.6 )
          Other-net .4 (.1 ) 1.5 2.1




             Net cash provided (used) by operating activities 1.8 2.5 (20.5 ) 22.3
   Investing activities cash flows
       Capital expenditures (1.1 ) (.8 ) (4.1 ) (3.6 )
       Net disposals of property, plant and equipment .1 1.7 2.4 7.3
       Divestitures 4.1 308.8 (20.3 ) 308.8
       Acquisitions - - (6.5 ) (1.9 )




             Net cash provided (used) by investing activities 3.1 309.7 (28.5 ) 310.6
   Financing activities cash flows
       Dividends paid - (.4 ) (.8 ) (1.2 )
       Issuance of long-term debt - - - 11.5
       Repayments of long-term debt (.7 ) (.2 ) (1.7 ) (.7 )
       Decrease in borrowings under lines of credit (1.5 ) (266.5 ) (2.8 ) (311.2 )
       Puchase of treasury and other common shares - - - .4




          Net cash used by financing activities (2.2 ) (267.1 ) (5.3 ) (301.2 )
Effect of exchange rate fluctuations on cash and
   cash equivalents
(.8 ) (.3 ) 6.2 1.4
Cash flows related to discontinued operations (6.3 ) (5.9 ) (11.4 ) (9.0 )




Increase (Decrease) in cash and cash equivalents (4.4 ) 38.9 (59.5 ) 24.1
Cash and cash equivalents at beginning of period 67.2 75.3 122.3 90.1




Cash and cash equivalents at end of period $ 62.8 $ 114.2 $ 62.8 $ 114.2





See notes to consolidated condensed financial statements.

5


Notes to Consolidated Condensed Financial Statements
(Unaudited)

Basis of Presentation
      In the opinion of management, the accompanying unaudited Consolidated Condensed Financial Statements contain all adjustments, including only normal recurring adjustments except for the matters discussed in the notes captioned "Discontinued Operations," "Goodwill Impairment Charge," "Restructuring Costs" and "Income Taxes," necessary to present fairly the company's financial position, results of operations and cash flows.

      The Consolidated Condensed Balance Sheet at December 31, 2002 has been derived from the audited Consolidated Financial Statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.

      The accounting policies followed by the company are set forth in the "Summary of Significant Accounting Policies" note to the Consolidated Financial Statements included in the company's Annual Report on Form 10-K for the year ended December 31, 2002.

Stock-Based Compensation
      The company accounts for stock-based compensation, including stock options, under the provisions of Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees," and the related interpretations. Because all stock options outstanding under the company's 1997 Long-Term Incentive Plan and prior plans have exercise prices equal to the fair market value of the underlying common shares at the respective grant dates, no compensation expense is recognized in earnings. The following table illustrates on a pro forma basis the effect on net earnings or loss and earnings or loss per common share if the stock options granted from 1995 through 2003 had been accounted for based on their fair values as determined under the provisions of Statement of Financial Accounting Standards No. 123, "Accounting for Stock-Based Compensation.


Pro forma Loss

    Three Months Ended
Sept. 30,
    Nine Months Ended
Sept. 30,
   
   
(In millions, except per-share amounts) 2003    2002 2003    2002

Net earnings (loss) as reported $ (67.7 ) $ 14.5 $ (167.3 ) $ (217.4 )
Effect on reported earnings (loss) of accounting for stock options
   at fair value
(.1 ) (.4 ) (.5 ) (1.7 )




Pro forma net earnings (loss) $ (67.8 ) $ 14.1 $ (167.8 ) $ (219.1 )




Earnings (loss) per common share -
   basic and diluted
      As reported $ (2.01 ) $ .43 $ (4.98 ) $ (6.50 )




      Pro forma $ (2.01 ) $ .42 $ (4.99 ) $ (6.55 )





Change in Method of Accounting
      Effective January 1, 2002, the company adopted Statement of Financial Accounting Standards No. 142, "Goodwill and Other Intangible Assets." As required by this standard, during 2002 the company completed the transitional reviews of recorded goodwill balances as of January 1, 2002. These transitional reviews resulted in a pretax goodwill impairment charge of $247.5 million ($187.7 million after tax or $5.61 per share) that was recorded as the cumulative effect of a change in method of accounting as of January 1, 2002. Approximately 75% of the pretax charge related to the company's Uniloy and round metalcutting tools businesses, the latter of which is now reported as a discontinued operation.

Discontinued Operations
      In the third quarter of 2002, the company announced a strategy of focusing its capital and resources on building its position as a premier supplier of plastics processing technologies and strengthening its worldwide industrial fluids business. In connection with this strategy, during 2002 the company sold two businesses that had been included in its former metalworking technologies segment and initiated efforts to seek strategic alternatives for two other businesses of the segment.

      On August 30, 2002, the company completed the sale of its Widia and Werkö metalcutting tools business to Kennametal, Inc. for €188 million in cash (approximately $185 million), subject to post-closing adjustments. In a separate but contingent transaction, the company purchased an additional 26% of the shares of Widia India, thereby increasing its ownership interest from 51% to 77%. The entire 77% of the Widia India shares was included in the sale transaction. After deducting post-closing adjustments of approximately $20 million that were paid in the first quarter of 2003, transaction costs and the cost to increase the company's ownership interest in Widia India, the ultimate net cash proceeds from the sale were approximately $135 million, most of which was used to repay bank borrowings. In the second quarter of 2002, the company recorded an estimated loss on the anticipated sale of $15.3 million. Based on the actual sale proceeds and costs, the loss was adjusted to $14.9 million in the fourth quarter of the year. Approximately $7 million of the loss resulted from the recognition of the cumulative foreign currency translation adjustments that had been recorded in accumulated other comprehensive loss since the acquisition of Widia in 1995.


6


      On August 9, 2002, the company completed the sale of its Valenite metalcutting tools business to Sandvik AB for $175 million in cash. After deducting post-closing adjustments of approximately $4 million that were paid in the first quarter of 2003, transaction costs and sale-related expenses, the net cash proceeds from the sale were approximately $145 million, a majority of which was used to repay bank borrowings. The company recorded an after-tax gain on the sale of $29.4 million in the third quarter of 2002 which was adjusted to $31.3 million in the fourth quarter to reflect actual proceeds and expenses.

      During the third quarter of 2002, the company retained advisors to explore strategic alternatives for its round metalcutting tools and grinding wheels businesses and in the fourth quarter, initiated plans for their sale. The disposition of the round metalcutting tools business was completed in the third quarter of 2003 in two separate transactions that resulted in a combined after-tax loss of $4.7 million. In the fourth quarter of 2002, the company had recorded an estimated loss on the sale of this business of $4.7 million so there was no effect on earnings in the third quarter of 2003. The sale of the grinding wheels business is expected to be completed later in 2003 or early in 2004.

      All of the businesses discussed above are reported as discontinued operations and the Consolidated Condensed Financial Statements for all prior periods have been adjusted to reflect this presentation. Operating results for all of the businesses included in discontinued operations are presented in the following table.


Loss from Discontinued Operations

    Three Months Ended
Sept. 30,
    Nine Months Ended
Sept. 30,
   
   
(In millions) 2003    2002 2003    2002

Sales $ 12.3 $ 70.1 $ 44.7 $ 307.9




Operating loss (1.6 ) (12.4 ) (4.4 ) (25.8 )
Allocated interest expense (.4 ) (2.7 ) (1.3 ) (10.5 )




Loss before income taxes and minority shareholders' interests (2.0 ) (15.1 ) (5.7 ) (36.3 )
Provision (benefit) for income taxes - (3.6 ) - (9.8 )




Loss before minority shareholders' interests (2.0 ) (11.5 ) (5.7 ) (26.5 )
Minority shareholders' interests - (1.1 ) - (2.1 )




Loss from discontinued operations $ (2.0 ) $ (10.4 ) $ (5.7 ) $ (24.4 )





      As reflected in the preceding table, allocated interest expense includes interest on debt assumed by the respective buyers, interest on borrowings that were required to be repaid using a portion of the proceeds from the Widia and Werkö transaction and the Valenite transaction, interest on borrowings secured by assets of the businesses sold, and an allocated portion of other consolidated interest expense based on the ratio of net assets sold or to be sold to consolidated assets.

      The major classes of assets and liabilities of the discontinued grinding wheels and round metalcutting tools businesses in the Consolidated Condensed Balance Sheets as of September 30, 2003 and December 31, 2002 are as follows:


7



Assets and Liabilities of Discontinued Operations

(In millions)     Sept. 30,
2003
    Dec. 31,
2002

Notes and acounts receivable .7 1.4
Inventories 3.4 7.9
Other current assets 2.8 .1
Property, plant and equipment-net 2.1 6.6


   Total assets 9.0 16.0
Current portion of long-term debt - .4
Trade accounts payable 1.5 4.4
Other current liabilities .6 1.4
Long-term debt - 2.7
Long-term accrued liabilities .2 2.0


   Total liabilities 2.3 10.9


Net Assets $ 6.7 $ 5.1



Goodwill Impairment Charge
      In the third quarter of 2003, the company recorded a goodwill impairment charge of $52.3 million (with no tax benefit) to adjust the carrying value of the goodwill of two businesses included in the mold technologies segment. The charge resulted from a downward adjustment of the future cash flows expected to be generated by these businesses due to the delay in the general economic recovery both in North America and Europe. The largest decrease in cash flow expectations related to the company's European mold base and components business due to continued weakness in the markets it serves. The third quarter charge - which was calculated by discounting estimated future cash flows - is preliminary and may be adjusted in the fourth quarter based on revised estimates of the fair values of certain tangible and intangible assets. The amount of any future adjustments cannot be determined at this time.

Restructuring Costs
      In 2001, the company's management formally approved plans to consolidate certain manufacturing operations and reduce the company's cost structure. Implementation of these plans resulted in pretax charges to earnings from continuing operations of $17.8 million, of which $4.2 million was charged to expense in the first three quarters of 2002. As they relate to continuing operations, the 2001 plans involved the closure of four manufacturing facilities in North America and the elimination of approximately 450 manufacturing and administrative positions. The cash cost of implementing the plans was $11.2 million, of which $10.7 million was spent in the first three quarters of 2002.

      During 2001, the company's management also approved a plan to integrate the operations of EOC and Reform, two businesses that were acquired earlier in that year, with the company's existing European mold base and components business. The total cost of the integration was $9.8 million, of which $1.2 million was included in reserves for employee termination benefits and facility exit costs that were established in the allocations of the EOC and Reform acquisition costs. The remainder was charged to expense, including $4.3 million in the first three quarters of 2002 and $.6 million in the first three quarters of 2003. As approved by management, the plan involved the consolidation of the manufacturing operations of five facilities located in Germany and Belgium into three facilities, the reorganization of warehousing and distribution activities in Europe, and the elimination of approximately 230 manufacturing and administrative positions. The total cash cost of the integration plan was $9.2 million, of which $7.4 million was spent in the first three quarters of 2002.

      In the third quarter of 2002, the company's management approved additional restructuring plans for the purpose of further reducing the company's cost structure in certain businesses and to reduce corporate costs as a result of the disposition of Widia, Werkö and Valenite. These actions resulted in third quarter, 2002 restructuring costs of $1.3 million.

      In November, 2002, the company announced additional restructuring initiatives intended to improve operating efficiency and customer service. The first action involved the transfer of all manufacture of container blow molding machines and structural foam systems from the plant in Manchester, Michigan to the company's more modern and efficient facility near Cincinnati, Ohio. The mold making operation in Manchester will also move to a smaller location near the existing facility. In another initiative, the manufacture of special mold bases for injection molding at the Monterey Park, California plant has been phased out and transferred to various other facilities in North America. These additional actions are expected to result in incremental restructuring costs of approximately $9.0 million. Of the total cost of the actions, $4.3 million was charged to expense in the fourth quarter of 2002. An additional $4.4 million was expensed in the first three quarters of 2003. The net cash cost of these initiatives is currently expected to be approximately $4 million, substantially all of which will be spent in 2003, including $2.8 million in the first three quarters. Both amounts are net of $1.5 million of proceeds from the sale of the Monterey Park plant that was received in the second quarter of 2003. The pretax annualized cost savings are expected to exceed $4 million, a majority of which will be realized in 2003.


8


      Early in 2003, the company initiated a plan for the further restructuring of its European blow molding machinery operations at a cost of $4.6 million, all of which was charged to expense in the first three quarters of the year. The restructuring involves the discontinuation of the manufacture of certain product lines at the plant in Magenta, Italy and the elimination of approximately 35 positions. The cash cost of the restructuring - all of which will be spent in 2003 - is expected to be approximately $1 million. Of this amount, $.6 million was spent in the first three quarters of the year. The annualized pretax savings are expected to be approximately $3 million, which began to be realized in the first quarter of 2003.

      Early in the second quarter of 2003, the company initiated a plan to close its special mold base machining operation in Mahlberg, Germany and relocate a portion of its manufacturing to another location. Certain other production is being outsourced. The closure is expected to result in restructuring costs of approximately $3.8 million and the elimination of approximately 65 positions. Of the total cost, $2.9 million was charged to expense in the second and third quarters of 2003. Cash costs are expected to be approximately $3 million and the annual cost savings are expected to be in excess of $3 million.

      Early in the third quarter of 2003, the company announced additional restructuring initiatives that focus on further overhead cost reductions in each of its plastics technologies segments and at the corporate office. These actions, which involve the relocation of production, closure of sales offices, voluntary early retirement programs and general overhead reductions, are expected to result in the elimination of approximately 300 positions worldwide at a cost of $11 to $12 million during the second half of 2003. A total of $6.0 million was charged to expense in the third quarter in connection with these initiatives. Cash costs related to these initiatives will be approximately $8 to $9 million, of which $1.7 million was spent in the third quarter of 2003. An additional $4 million is expected to be spent in the fourth quarter. The annual cost savings are expected to be approximately $19 million.

      For all of 2003, restructuring costs related to the actions discussed above, including $4 to $5 million to complete the actions initiated in 2002, are expected to total between $25 and $26 million. Cash costs for the year are expected to be approximately $14 million of which approximately $4 to $5 million remains to be spent in the fourth quarter.

      The following table presents the components of the restructuring costs that are included in the Consolidated Condensed Statements of Operations for the third quarters of 2003 and 2002 and the nine month periods ended September 30, 2003 and 2002.


Restructuring Costs

    Three Months Ended
Sept. 30,
    Nine Months Ended
Sept. 30,
   
   
(In millions) 2003    2002 2003    2002

Accruals for termination benefits and facility exit costs $ 1.0 $ - $ 4.6 $ .6
Supplemental retirement benefits 3.2 .8 3.2 2.9
Other restructuring costs
   Costs charged to expense as incurred 2.2 .6 11.5 2.0
   Reserve adjustments - - (1.3 ) -




6.4 1.4 18.0 5.5
Costs related to EOC and Reform integrations - .5 .6 4.3




Total restructruing costs $ 6.4 $ 1.9 $ 18.6 $ 9.8






9


      The status of the reserves for the initiatives discussed above, as well as certain other reserves that were established in 1999 in connection with the consolidation of the company's European blow molding machinery operations, is summarized in the following tables. The amounts included therein relate solely to continuing operations. To the extent that any reserves that were established in the allocation of acquisition cost remain after the completion of the EOC and Reform integration, those amounts will be applied as reductions of goodwill arising from the respective acquisitions.


Restructuring Reserves

    Three Months Ended
Sept. 30, 2003
    Nine Months Ended
Sept. 30, 2003
   
   
(In millions)    
Beginning
Balance

Addi-
tions

Usage and
Other

Ending
Balance
   
Beginning
Balance

Addi-
tions

Usage and
Other

Ending
Balance

EOC and Reform integration
      Termination benefits       $ 1.4   $ -   $ - $ 1.4       $ 1.7   $ -   $ (.3 ) $ 1.4
Restructuring costs                    
      Termination benefits     1.1 1.0 (.5 ) 1.6     3.1 4.6 (6.1 ) 1.6
      Facility exit costs     - - - -     .6 - (.6 ) -
       



   



    &n